Search Results
(±)-Warfarin Sodium Clathrate 25 g | ≥98%
LKT Laboratories, Inc.
(±)-Warfarin-d5 1 mg | ≥99%
Cayman Chemical
(±)-Warfarin-d5
(±)-Warfarin-d5 500 µg | ≥99%
Cayman Chemical
(±)-Warfarin-d5
(±)-WIN 55,212 (mesylate) 50 mg | ≥98%
Cayman Chemical
(±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 25 mg | ≥98%
Cayman Chemical
(±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 10 mg | ≥98%
Cayman Chemical
(±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 5 mg | ≥98%
Cayman Chemical
(±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 25mg | ≥90%
Musechem
(±)-WIN 55,212 (mesylate) 5 mg | Purity Not Available
TargetMol
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively. In contrast, the enantiomer (-)-WIN 55,212-3 acts a partial inverse agonist at CB1 (pIC50 = 5.5) and as a competitive neutral antagonist of CB2, […]
More Information Supplier Page(±)-WIN 55,212 (mesylate)
(±)-WIN 55,212 (mesylate) 10 mg | Purity Not Available
TargetMol
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively. In contrast, the enantiomer (-)-WIN 55,212-3 acts a partial inverse agonist at CB1 (pIC50 = 5.5) and as a competitive neutral antagonist of CB2, […]
More Information Supplier Page(±)-WIN 55,212 (mesylate)